Juan-Carlos Hernández-Boluda

81PUBLICATIONS
290CO-AUTHORS
Haematological tumoursMedical biotechnology diagnostics (incl. biosensors)Respiratory diseasesCardiovascular medicine and haematology not elsewhere classifiedCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (81)

|Aug 04, 2026
Survival outcomes and treatment patterns in myelofibrosis in the JAK inhibitor era.

|Jul 15, 2026
Impact of Hemoglobin Improvement on Survival in Patients With Myelofibrosis and Anemia Treated With Momelotinib in the SIMPLIFY-1 and MOMENTUM Trials.

|Jul 13, 2026
Mutational profile and cardiovascular risk factors impact prognosis in triple-negative essential thrombocythemia.

|May 07, 2026
Impact of thrombosis on disease progression, cancer and mortality in patients with essential thrombocythemia and polycythemia vera.

|Apr 01, 2026
Defining remission and relapse after allogeneic hematopoietic cell transplantation in myelodysplastic/myeloproliferative neoplasms and optimization of transplantation outcomes: Recommendations from the EBMT practice harmonisation and guidelines committee.

Christopher Armstrong, Kavita Raj, Giorgia Battipaglia

|Mar 21, 2026
Decreased Chronic GvHD With Post-Transplant Cyclophosphamide Versus ATG in Patients With Myelofibrosis Allografted With an Unrelated Donor: A Study From the Chronic Malignancies Working Party of the EBMT.

Yves Chalandon, Edouard F Bonneville, Diderik-Jan Eikema

Pageof 14

Frequent Collaborators

22 joint publications

Donal P McLornan

20 joint publications

Marie Robin

18 joint publications

Nicola Polverelli

14 joint publications

Tomasz Czerw